Fierce Women in Biopharma 2016

October 13, 2016

2016 has been a trailblazing year for women in biopharma! Emma Walmsley, whom was featured on this list last year, was selected as the next CEO of GlaxoSmithKline, making her the first woman to lead a Big Pharma company. But she’s not the first woman to make a major impact on her company or industry. This year, FiercePharma features 15 women who are doing just that from a variety positions:

1. Azita Saleki-Gerhardt – AbbVie

2. Vicki Goodman – Bristol-Myers Squibb

3. Rachel Haurwitz – Caribou Biosciences

4. Charlotte Hubbert – Gates Foundation Venture Capital

5. Farah Champsi – InterWest Partners

6. Julia Owens – Millendo Therapeutics

7. Carole Nuechterlein – Roche

8. Karen Linehan – Sanofi

9. Jane Osbourn – AstraZeneca’s MedImmune

10. Daphne Koller – Calico Labs

11. Aarti Shah – Eli Lilly

12. Deborah Waterhouse – GlaxoSmithKline